Nexafed
Nexafed is a special formulation of pseudoephedrine developed by Acura Pharmaceuticals used to deter the use of the pseudoephedrine contained in the product for illicit methamphetamine synthesis.[1] Nexafed uses a polymer matrix that forms a thick gel when hydrated, preventing the extraction of pseudoephedrine. Nexafed is the only meth-resistant formulation of pseudoephedrine that shows therapeutic equivalence to Sudafed.
It is sold at various pharmacies in the US, including Fruth Pharmacy[2][3] and Kroger, particularly in communities where illicit methamphetamine production is an issue.
References
- ^ "In fight against crystal meth, a focus on chemistry". cbsnews.com. Retrieved 18 July 2016.
- ^ "Fruth Pharmacy recognized for fighting meth production". drugstorenews.com. Retrieved 18 July 2016.
- ^ Anna Baxter, The Associated Press. "Fruth Pharmacy to Stop Selling Certain Medications to Fight Meth Abuse". wsaz.com. Retrieved 18 July 2016.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |